US clears Moderna jab for use as second Covid-19 vaccine
Moderna and manufacturing partner Lonza plan to produce 500-million to 1-billion total doses of its vaccine in 2021
19 December 2020 - 14:01
Moderna’s Covid-19 vaccine has been cleared by US regulators, the second vaccine to gain emergency authorisation in December as a historic mass immunisation effort ramps up across the country.
The Food and Drug Administration’s (FDA) decision to grant the authorisation on Friday for the shot’s use among adults means that two of the six vaccine candidates identified by Operation Warp Speed are now available to the public, a feat accomplished in less than one year. Shots from AstraZeneca and Johnson & Johnson that have also received US government support are expected to be submitted for review in 2021...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.